Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation

« Previous Next »The Journal of Heart and Lung Transplantation
Volume 29, Issue 6 , Pages 641-647, June 2010

Einar Gude, MD
- Department of Cardiology, Oslo University Hospital, Oslo, Norway
- Reprint requests: Einar Gude, MD, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo 0027, Norway. Telephone: +47-23-07-00-00. Fax: +47-23-07-19-50
Lars Gullestad, MD, PhD
- Department of Cardiology, Oslo University Hospital, Oslo, Norway
- Rikshospitalet and Faculty Division, University of Oslo, Oslo, Norway
Satish Arora, MD
- Rikshospitalet and Faculty Division, University of Oslo, Oslo, Norway
Svein Simonsen, MD, PhD
- Department of Cardiology, Oslo University Hospital, Oslo, Norway
Ina Hoel, RN
- Department of Cardiology, Oslo University Hospital, Oslo, Norway
Anders Hartmann, MD, PhD
- Rikshospitalet and Faculty Division, University of Oslo, Oslo, Norway
- Department of Internal Medicine, Oslo University Hospital, Oslo, Norway
Hallvard Holdaas, MD, PhD
- Department of Internal Medicine, Oslo University Hospital, Oslo, Norway
Arnt E. Fiane, MD, PhD
- Rikshospitalet and Faculty Division, University of Oslo, Oslo, Norway
- Department of Thoracic and Cardiovascular Surgery, Oslo University Hospital, Oslo, Norway
Odd R. Geiran, MD, PhD
- Rikshospitalet and Faculty Division, University of Oslo, Oslo, Norway
- Department of Thoracic and Cardiovascular Surgery, Oslo University Hospital, Oslo, Norway
Arne K. Andreassen, MD, PhD
- Department of Cardiology, Oslo University Hospital, Oslo, Norway